|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | CeCl_3·7H_2O-SiO_2:Catalyst promoted microwave assisted neat synthesis,antifungal and antioxidant activities of α-diaminophosphonates显示文摘CeCl3 汃″ ??? 伲匭佩 ? ? 賥芉铦膌? ?? ? 諥?? 蒚郥邈 ? 鞊鳧? 貏 ? 钸 ? 楤浡湩灯潨灳潨慮整 ? 髧鞊 ? 隌觥? 諥¨ ?? 泔?? | Subba Rao Devineni Srinivasulu Doddaga Rajasekhar Donka Naga Raju Chamarthi | 2013 | Chinese Chemical Letters2013，24，8： | 3 |
| 2 | Synthesis,isolation,identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC,LC/ESI-MS and NMR显示文摘One unknown impurity(Imp-Ⅱ) during the analysis of laboratory batches of isoproterenol hydrochloride was detected in the level ranging from 0.04% to 0.12% by high performance liquid chromatography with UV detection. The unknown impurity structure was proposed as 4-[2-(propan-2-ylamino)ethyl]benzene-1,2-diol(Imp-Ⅱ) using the liquid chromatography–mass spectrophotometry(LC–MS) analysis. Imp-Ⅱ was isolated by semi-preparative liquid chromatography from the impurity-enriched reaction crude sample. Its proposed structure was confirmed by nuclear magnetic spectroscopy such as ~1H,^(13)C, DEPT(1D NMR), HSQC(2D NMR)and infrared spectroscopy(IR), and retention time and purity with HPLC followed by the chemical synthesis.Due to less removable nature of Imp-Ⅱ during the purification, the synthetic process was optimized proficiently to control the formation of Imp-Ⅱ below to the limit < 0.12% in the course of reaction. The new chemical route was developed for the preparation of this impurity in required quantity with purity to use as reference standard.The most probable mechanism for the formation of Imp-Ⅱ was discussed in details. | Neeraj Kumar Subba Rao Devineni Prasad Reddy Gajjala Shailendra Kumar Dubey Pramod Kumar | 2017 | Journal of Pharmaceutical Analysis2017，7，6： | 2 |
| 3 | Preparation, characterization, cytotoxicity and transfection efficiency of poly ( dl-lactide-co-glycolide ) and poly ( dl-lactic acid ) cationic nanoparticles for controlled delivery of plasmid DNA 显示文摘 | Ashwin Basarkar Dilip Devineni | 2007 | International Journal of Pharmaceutics2007，343，12： | 1 |
| 4 | Preparation, charac- terizatlon, cytotoxicity and transfection efficiency of poly(DL-lactide-co- glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA 显示文摘 | Basarkar A Devineni D Palaniappan R Singh J | 2007 | Int J Pharm2007，343，12： | 1 |
| 5 | Pharmcolcinetics of nateglinide in renally impaired diabertic patients显示文摘 | Devineni D Walter Y H Smith H T | 2003 | J Clin Pharmacol2003，43，2： | 1 |
| 6 | Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors显示文摘 | DEVINENI D KLENI-SZANTO A | 1995 | J Neurooncol1995，24，1： | 1 |
| 7 | Canagliflozin, a novel inhibitor ofsodium glucose co-transporter 2,dose dependently reduces calculatedrenal threshold for glucose excretion and increases urinary glucoseexcretion in healthy subjects 显示文摘 | Sha S Devineni D Ghosh A | 2011 | Diabetes Obesity & Metabolism2011，13，7： | 1 |
| 8 | In vivo microdialysis to characterize drug transport in brain tumors:analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats显示文摘 | DEVINENI D KLEIN-SZANTO A GAHO J M | 1996 | Cancer Chemother Pharmacol1996，38，6： | 1 |
| 9 | Pharmacokinetics of nateglinide in renally impaired diabetic patients显示文摘 | Devineni D Walter Y H Smith H T | 2003 | J Clin Pharmacol2003，43，2： | 1 |
| 10 | Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems 显示文摘 | Devineni D Blanton CD Gallo JM | 2005 | Bioconjug Chem2005，6，2： | 1 |
| 11 | 显示文摘 | Ashwin Basarkar Dilip Devineni Ravi Palaniappan Jagdish Singh | 2007 | International Journal of Pharmaeeuties2007，343，12： | 1 |
| 12 | Pharmacokinetics of nateglinide in renally impaired diabetic patients显示文摘 | Devineni D Walter YH Smith HT | 2003 | J Clin Pharmacol2003，43，2： | 1 |
| 13 | Pharmacokinetics of nateglinide in renally impaired diabetic patients 显示文摘 | Devineni D Walter YH Smith HT | 2003 | J Clin Pharmacol2003，43，2： | 1 |
| 14 | Carcinoma of nasopharynx:factors affecting prognosis显示文摘 | Devineni VR Marcial-Vega V | 1992 | Int J Radiat Oncol Bil Phys1992，23，2： | 1 |
| 15 | Inhibition of expression of antiapoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line(PC-3)by methyl jasmonate显示文摘 | Ezekwudo D Shashidharamurthy R Devineni D | 2008 | Cancer Lett2008，270，2： | 1 |
| 16 | The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx显示文摘 | MARKS J E DEVINENI V R HARVEY J | 1992 | Am J Otolaryngol1992，13，： | 1 |
| 17 | Carcinoma of the nasopharynx: factors affecting prognosis显示文摘 | Perez C A Devineni V R Marcial2Vega V | 1992 | Int J Radiat Oncol Biol Phys1992，23，2： | 1 |
| 18 | Pharmacok inetics of nateglinide in renally im paired diabetic patients显示文摘 | Devineni D Walter Y H Smith H T er al | 2003 | J Clin Pharmacol2003，43，2： | 1 |
| 19 | In vivo microdialysis to characterize drug transport brain tumors:analysis of methotrexate uptake in rat glioma-2(RG-2)-beafing rats显示文摘 | Devineni D Klein-Szanto A Galld JM | 1996 | Cancer Chemother Pharmacol1996，38，6： | 1 |
| 20 | Carcinoma of the nasopharynx: Factors affecting prognosis 显示文摘 | Devineni VR Marcial-Vega V | 1992 | Int J Radiat Oncol Biol Phys1992，23，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员